Your session is about to expire
← Back to Search
Chemotherapy +/− Surgery + Mitomycin C for Colorectal Cancer
Study Summary
This trial is studying standard therapy with or without surgery and mitomycin C to see how well it works in treating patients with advanced limited peritoneal dissemination of colon cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Arm I
- Group 2: Arm II
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any dangers to using bevacizumab?
"There is some evidence backing the efficacy of bevacizumab as well as numerous rounds of data affirming its safety, so it received a 3."
What are some standard treatments that involve bevacizumab?
"bevacizumab is a medication with diverse applications. Small cell lung cancer (sclc) is the primary condition that bevacizumab is used to treat. However, it can also be used as a treatment for glaucoma, rectal carcinoma, and colorectal carcinoma."
Are there any vacant slots in this clinical trial for new patients?
"This particular clinical trial is not recruiting at the moment. The first posting was on August 1st, 2010 and the last edit was on January 21st, 2012. If the individual is looking for other studies, there are 1257 trials for colorectal cancer and 1277 bevacizumab trials that are currently recruiting patients."
Could you tell us about other investigational uses of bevacizumab?
"Bevacizumab was first studied in 2000 at Wellington Hospital. Since then, there have been 2709 completed clinical trials. There are currently 1277 active studies, with a large number being performed out of Winston-Salem, North carolina."
How many guinea pigs are being used in this experiment?
"This study is not recruiting patients at the moment. It was originally posted on 8/1/2010 and was last edited on 1/21/2012. If you are interested in other studies, there are 1257 trials for colorectal cancer and 1277 trials for bevacizumab that are actively enrolling patients."
Share this study with friends
Copy Link
Messenger